Our website is made possible by displaying online advertisements to our visitors.
Please consider supporting us by disabling your ad blocker. Please reload after ad blocker is disabled.
Next Post
Coronavirus | Pharma firms Zenara, BDR get DCGI nod for Favipiravir versions
Wed Aug 5 , 2020
Two more pharma companies, Zenara of Hyderabad and the Mumbai-headquartered BDR, have joined a growing list of drugmakers launching anti-viral drug Favipiravir versions for use in the treatment of COVID-19 patients in India. On Wednesday, the two companies said the Drugs Controller General of India (DCGI) has given them approval […]

You May Like
-
6 years ago
एक क्लिक में पढिय़े दिनभर की 20 बड़ी खबरें
-
6 years ago
CM asks BJDMLAs to join COVID-19 fight
-
6 years ago
Baghjan blowout: panel faults OIL on safety